Operating Income (Loss) of KESTRA MEDICAL TECHNOLOGIES, LTD. from 30 Apr 2024 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
KESTRA MEDICAL TECHNOLOGIES, LTD. quarterly and annual Operating Income (Loss) in USD history and change rate from 30 Apr 2024 to 31 Oct 2025.
  • KESTRA MEDICAL TECHNOLOGIES, LTD. Operating Income (Loss) for the quarter ending 31 Oct 2025 was $31,755,000, a 66% decline year-over-year.
  • KESTRA MEDICAL TECHNOLOGIES, LTD. annual Operating Income (Loss) for 2024 was $106,378,000, a 25% decline from 2023.
Source SEC data
View on sec.gov
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

KESTRA MEDICAL TECHNOLOGIES, LTD. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $31,755,000 -$12,621,000 -66% 01 Aug 2025 31 Oct 2025 10-Q 11 Dec 2025 2025 Q2
Q2 2025 $28,878,000 -$10,447,000 -57% 01 May 2025 31 Jul 2025 10-Q 12 Sep 2025 2025 Q1
Q3 2024 $19,134,000 01 Aug 2024 31 Oct 2024 10-Q 11 Dec 2025 2025 Q2
Q2 2024 $18,431,000 01 May 2024 31 Jul 2024 10-Q 12 Sep 2025 2025 Q1

KESTRA MEDICAL TECHNOLOGIES, LTD. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $106,378,000 -$21,315,000 -25% 01 May 2024 30 Apr 2025 10-K 17 Jul 2025 2025 FY
2023 $85,063,000 01 May 2023 30 Apr 2024 10-K 17 Jul 2025 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.